Translational Development Acquisition Corp. Units
Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
Market Cap & Net Worth: Translational Development Acquisition Corp. Units (TDACU)
Translational Development Acquisition Corp. Units (NASDAQ:TDACU) has a market capitalization of $103.91K ($103.91K) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #16734 globally and #6413 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Translational Development Acquisition Corp. Units's stock price $10.44 by its total outstanding shares 9953 (9.95K).
Translational Development Acquisition Corp. Units Market Cap History: 2025 to 2026
Translational Development Acquisition Corp. Units's market capitalization history from 2025 to 2026. Data shows growth from $103.91K to $103.91K (0.00% CAGR).
Translational Development Acquisition Corp. Units Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Translational Development Acquisition Corp. Units's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of TDACU by Market Capitalization
Companies near Translational Development Acquisition Corp. Units in the global market cap rankings as of March 18, 2026.
Key companies related to Translational Development Acquisition Corp. Units by market ranking:
- CLUS (PINK:CLUS): Ranked #1961 globally with a market cap of $8.00 Billion USD.
- Cartesian Growth Corporation II Warrant (NASDAQ:RENEW): Ranked #8548 globally with a market cap of $736.93 Million USD.
- Nh Special Purpose Acquisition 14 Co. Ltd (KQ:319400): Ranked #8998 globally with a market cap of $660.01 Million USD ( ₩966.39 Billion KRW).
- EQV Ventures Acquisition Corp. II (NYSE:EVAC): Ranked #10601 globally with a market cap of $466.44 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1961 | CLUS | PINK:CLUS | $8.00 Billion | $200.00 |
| #8548 | Cartesian Growth Corporation II Warrant | NASDAQ:RENEW | $736.93 Million | $138.87 |
| #8998 | Nh Special Purpose Acquisition 14 Co. Ltd | KQ:319400 | $660.01 Million | ₩29800.00 |
| #10601 | EQV Ventures Acquisition Corp. II | NYSE:EVAC | $466.44 Million | $10.09 |
Translational Development Acquisition Corp. Units Historical Marketcap From 2025 to 2026
Between 2025 and today, Translational Development Acquisition Corp. Units's market cap moved from $103.91K to $ 103.91K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $103.91K | 0.00% |
| 2025 | $103.91K | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Translational Development Acquisition Corp. Units was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $103.91K USD |
| MoneyControl | $103.91K USD |
| MarketWatch | $103.91K USD |
| marketcap.company | $103.91K USD |
| Reuters | $103.91K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.